These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27474100)

  • 1. Association of FOXE1 polyalanine repeat region with thyroid cancer is dependent on tumour size.
    Raimundo J; Alvelos MI; Azevedo T; Martins T; Rodrigues FJ; Lemos MC
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):243-246. PubMed ID: 27474100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.
    Tomaz RA; Sousa I; Silva JG; Santos C; Teixeira MR; Leite V; Cavaco BM
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):926-33. PubMed ID: 22882326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma.
    Kallel R; Belguith-Maalej S; Akdi A; Mnif M; Charfeddine I; Galofré P; Ghorbel A; Abid M; Marcos R; Ayadi H; Velázquez A; Hadj Kacem H
    Cancer Biomark; 2010-2011; 8(1):43-51. PubMed ID: 21896990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of FOXE1 gene polymorphism with idiopathic premature ovarian failure].
    Qin C; Yao J; Yuan Z; Ren X; Xie J; Wu W
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):116-9. PubMed ID: 25877608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
    Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The investigation of foxe1 variations in papillary thyroid carcinoma.
    Somuncu E; Karatas A; Ferahman S; Saygili N; Yilmaz E; Ozturk O; Kapan M
    Int J Clin Exp Pathol; 2015; 8(10):13458-64. PubMed ID: 26722557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Mond M; Bullock M; Yao Y; Clifton-Bligh RJ; Gilfillan C; Fuller PJ
    Thyroid; 2015 Aug; 25(8):904-10. PubMed ID: 25950909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXE1 polyalanine tract length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid.
    Szczepanek E; Ruchala M; Szaflarski W; Budny B; Kilinska L; Jaroniec M; Niedziela M; Zabel M; Sowinski J
    Horm Res Paediatr; 2011; 75(5):329-34. PubMed ID: 21311165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXE1 association with differentiated thyroid cancer and its progression.
    Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
    Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
    Landa I; Ruiz-Llorente S; Montero-Conde C; Inglada-Pérez L; Schiavi F; Leskelä S; Pita G; Milne R; Maravall J; Ramos I; Andía V; Rodríguez-Poyo P; Jara-Albarrán A; Meoro A; del Peso C; Arribas L; Iglesias P; Caballero J; Serrano J; Picó A; Pomares F; Giménez G; López-Mondéjar P; Castello R; Merante-Boschin I; Pelizzo MR; Mauricio D; Opocher G; Rodríguez-Antona C; González-Neira A; Matías-Guiu X; Santisteban P; Robledo M
    PLoS Genet; 2009 Sep; 5(9):e1000637. PubMed ID: 19730683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.
    Mehrazin A; Safarpour H; Davoudi ST; Parsamanesh N; Saeedi F; Miri-Moghaddam E
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2771-2776. PubMed ID: 32986379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
    He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
    Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
    PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
    Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
    Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
    Bychkov A; Saenko V; Nakashima M; Mitsutake N; Rogounovitch T; Nikitski A; Orim F; Yamashita S
    Thyroid; 2013 Jul; 23(7):817-28. PubMed ID: 23327367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition of SNPs in miRNA-149 (rs2292832) and FOXE1 (rs3758249) in thyroid Cancer.
    Khan R; Shaheen H; Mansoor Q; Abbasi SA; Fatima S; Ammar A; Baig RM
    Mol Biol Rep; 2021 Dec; 48(12):7801-7809. PubMed ID: 34643920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis.
    Carré A; Castanet M; Sura-Trueba S; Szinnai G; Van Vliet G; Trochet D; Amiel J; Léger J; Czernichow P; Scotet V; Polak M
    Hum Genet; 2007 Dec; 122(5):467-76. PubMed ID: 17717707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXE1 polyalanine tract length screening by MLPA in idiopathic premature ovarian failure.
    Qin CR; Yao JL; Zhu WJ; Wu WQ; Xie JS
    Reprod Biol Endocrinol; 2011 Dec; 9():158. PubMed ID: 22177572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.